MedTrace Logo

Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms

NCT01641068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-11-08

No results posted yet for this study

Summary

The purpose of this study is to examine thinking abilities, mood, and quality of life in cancer survivors before and after an 8-week group-based memory and thinking skills workshop. Research participants will include people treated for cancer in the past. Researchers would like to know if there is a relationship between baseline performance on timed attention and memory tasks before receiving memory and thinking skills workshop designed to improve cognition, and performance on such tasks after the workshop.

Conditions

  • Breast Carcinoma
  • Cancer Survivor
  • Cognitive Side Effects of Cancer Therapy
  • Malignant Female Reproductive System Neoplasm

Interventions

OTHER

Cognitive Intervention

Participate in memory and thinking skills workshop

OTHER

Educational Intervention

Participate in workshops focusing on increasing knowledge and education on the brain and cognition

PROCEDURE

Functional Magnetic Resonance Imaging

Undergo functional neuroimaging

OTHER

Memory Intervention

Participate in memory and thinking skills workshop

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

Principal Investigators

  • Heidi Gray · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-12
Primary Completion
2018-01-01
Completion
2018-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01641068 on ClinicalTrials.gov